Co-Authors
This is a "connection" page, showing publications co-authored by NEDA KALHOR and CESAR MORAN.
Connection Strength
11.101
-
Thymomas With a Prominent Alveolar Growth Pattern: A Clinicopathologic and Immunohistochemical Study of 12 Cases. Am J Clin Pathol. 2019 01 07; 151(2):171-175.
Score: 0.667
-
Thymic epithelial neoplasms with sebaceous differentiation: a clinicopathological and immunohistochemical study of 8 cases. Hum Pathol. 2019 04; 86:124-128.
Score: 0.663
-
Thymic epithelial neoplasms with rhabdomyomatous component: a clinicopathological and immunohistochemical study of 7 cases. Hum Pathol. 2019 01; 83:100-105.
Score: 0.652
-
Pulmonary mucoepidermoid carcinoma: diagnosis and treatment. Expert Rev Respir Med. 2018 03; 12(3):249-255.
Score: 0.623
-
Primary thymic adenocarcinomas: a clinicopathological and immunohistochemical study of 16 cases with emphasis on the morphological spectrum of differentiation. Hum Pathol. 2018 04; 74:73-82.
Score: 0.623
-
Primary Salivary Gland Type Tumors of the Thymus. Adv Anat Pathol. 2017 Jan; 24(1):15-23.
Score: 0.580
-
Thymoma: current concepts. Oncology (Williston Park). 2012 Oct; 26(10):975-81.
Score: 0.432
-
Primary pulmonary chondrosarcomas: a clinicopathologic study of 4 cases. Hum Pathol. 2011 Nov; 42(11):1629-34.
Score: 0.390
-
Spindle cell thymomas (WHO Type A) with prominent papillary and pseudopapillary features: a clinicopathologic and immunohistochemical study of 10 cases. Am J Surg Pathol. 2011 Mar; 35(3):372-7.
Score: 0.387
-
Primary sclerosing neuroendocrine carcinomas of the lung: A clinicopathologic and immunohistochemical study of 10 cases. Am J Clin Pathol. 2010 Apr; 133(4):618-22.
Score: 0.363
-
Primary myxoma of the lung. Ann Diagn Pathol. 2010 Jun; 14(3):178-81.
Score: 0.356
-
So-called sclerosing hemangioma of lung: current concept. Ann Diagn Pathol. 2010 Feb; 14(1):60-7.
Score: 0.355
-
Typical and Atypical Carcinoid Tumors of the Mediastinum: A Biomarker Analysis of 27 Cases With Clinical Correlation. Int J Surg Pathol. 2021 Jun; 29(4):358-367.
Score: 0.190
-
Sarcomatoid Mesothelioma: A CDKN2A molecular analysis of 53 cases with immunohistochemical correlation with BAP1. Pathol Res Pract. 2020 Dec; 216(12):153267.
Score: 0.189
-
Mucous Gland Adenoma: The Spectrum of Growth Patterns and the Diagnostic Challenges. Adv Anat Pathol. 2020 Nov; 27(6):371-379.
Score: 0.189
-
Primary Mediastinal Yolk Sac Tumors: An Immunohistochemical Analysis of 14 Cases. Appl Immunohistochem Mol Morphol. 2019 02; 27(2):125-133.
Score: 0.167
-
Osteoclast-like giant cell-rich carcinomas of the lung: a clinicopathological, immunohistochemical, and molecular study of 3 cases. Hum Pathol. 2019 03; 85:168-173.
Score: 0.165
-
Thymoma: a clinicopathological correlation of 1470 cases. Hum Pathol. 2018 03; 73:7-15.
Score: 0.152
-
Cutaneous basal cell carcinoma with distant metastasis to thorax and bone : A clinicopathological and immunohistochemical study of 15 cases. Virchows Arch. 2017 Jun; 470(6):687-694.
Score: 0.148
-
Clinicopathologic and genetic features of primary bronchopulmonary mucoepidermoid carcinoma: the MD Anderson Cancer Center experience and comprehensive review of the literature. Virchows Arch. 2017 Jun; 470(6):619-626.
Score: 0.147
-
Expression of PD-1 and PD-L1 in thymic epithelial neoplasms. Mod Pathol. 2017 06; 30(6):826-833.
Score: 0.147
-
"Sarcomatoid" carcinomas of the lung: a clinicopathological study of 86 cases with a new perspective on tumor classification. Hum Pathol. 2017 05; 63:14-26.
Score: 0.144
-
Pleuromediastinal Epithelial-Myoepithelial Carcinomas: A Clinicopathologic and Immunohistochemical Study of Two Cases. Am J Clin Pathol. 2016 Dec; 146(6):736-740.
Score: 0.144
-
Ectopic Hamartomatous Thymoma-New Insights Into a Challenging Entity: A Clinicopathologic and Immunohistochemical Study of 9 Cases. Am J Surg Pathol. 2016 11; 40(11):1571-1576.
Score: 0.143
-
Intrathoracic glomus tumors and glomangiosarcomas: a clinicopathological and immunohistochemical study of 14 cases with emphasis on anatomic distribution. Virchows Arch. 2016 Nov; 469(5):541-546.
Score: 0.142
-
Spindle cell and pleomorphic ("sarcomatoid") carcinomas of the lung: an immunohistochemical analysis of 86 cases. Hum Pathol. 2017 01; 59:1-9.
Score: 0.141
-
Thymomas With Extensive Clear Cell Component: ?A Clinicopathologic and Immunohistochemical Study of Nine Cases. Am J Clin Pathol. 2016 Jul; 146(1):132-6.
Score: 0.140
-
Sebaceous lymphadenoma of the thymus: A clinicopathologic and immunohistochemical study of 2 cases. Hum Pathol. 2016 10; 56:189-93.
Score: 0.140
-
Cystic well-differentiated squamous cell carcinoma of the thymus: a clinicopathological and immunohistochemical study of six cases. Histopathology. 2016 Feb; 68(3):333-8.
Score: 0.131
-
Ewing sarcoma with extensive neural differentiation: a clinicopathologic, immunohistochemical, and molecular analysis of three cases. Am J Clin Pathol. 2015 May; 143(5):659-64.
Score: 0.129
-
An update on clinicopathological, immunohistochemical, and molecular profiles of colloid carcinoma of the lung. Hum Pathol. 2015 Jun; 46(6):836-42.
Score: 0.127
-
Thymic neuroendocrine tumors (paraganglioma and carcinoid tumors): a comparative immunohistochemical study of 46 cases. Hum Pathol. 2014 Dec; 45(12):2463-70.
Score: 0.123
-
Combined thymoma-thymic seminoma. Report of 2 cases of a heretofore unreported association. Hum Pathol. 2014 Oct; 45(10):2168-72.
Score: 0.122
-
Lung carcinoma: Beyond the WHO classification. Semin Diagn Pathol. 2014 Jul; 31(4):259.
Score: 0.121
-
Well-differentiated adenocarcinoma-bronchioloalveolar carcinoma-in situ adenocarcinoma: a conundrum. Adv Anat Pathol. 2013 Sep; 20(5):347-51.
Score: 0.115
-
Early-stage pulmonary adenocarcinoma (T1N0M0): a clinical, radiological, surgical, and pathological correlation of 104 cases. The MD Anderson Cancer Center Experience. Mod Pathol. 2013 Aug; 26(8):1065-75.
Score: 0.112
-
Thymomas I: a clinicopathologic correlation of 250 cases with emphasis on the World Health Organization schema. Am J Clin Pathol. 2012 Mar; 137(3):444-50.
Score: 0.104
-
Histologic patterns and molecular characteristics of lung adenocarcinoma associated with clinical outcome. Cancer. 2012 Jun 01; 118(11):2889-99.
Score: 0.101
-
Clinicopathological and immunohistochemical analysis of spindle-cell carcinoid tumour of the lung. Histopathology. 2011 Sep; 59(3):526-36.
Score: 0.100
-
Using the mitosis-specific marker anti-phosphohistone H3 to assess mitosis in pulmonary neuroendocrine carcinomas. Am J Clin Pathol. 2011 Aug; 136(2):252-9.
Score: 0.100
-
Spindle cell thymomas: an immunohistochemical study of 30 cases. Appl Immunohistochem Mol Morphol. 2011 Jul; 19(4):329-35.
Score: 0.099
-
Oncocytic neuroendocrine tumors of the lung: histopathologic spectrum and immunohistochemical analysis of 15 cases. Hum Pathol. 2011 Apr; 42(4):578-85.
Score: 0.096
-
Sox10-positive sustentacular cells in neuroendocrine carcinoma of the lung. Histopathology. 2011 Jan; 58(2):276-85.
Score: 0.096
-
Invasive spindle cell thymomas (WHO Type A): a clinicopathologic correlation of 41 cases. Am J Clin Pathol. 2010 Nov; 134(5):793-8.
Score: 0.095
-
Adenomatoid spindle cell thymomas: a clinicopathological and immunohistochemical study of 20 cases. Am J Surg Pathol. 2010 Oct; 34(10):1544-9.
Score: 0.094
-
Primary angiosarcomas of the anterior mediastinum: a clinicopathologic and immunohistochemical study of 9 cases. Hum Pathol. 2010 Dec; 41(12):1711-7.
Score: 0.093
-
Histologic features of low- and intermediate-grade neuroendocrine carcinoma (typical and atypical carcinoid tumors) of the lung. Lung Cancer. 2011 Jan; 71(1):34-41.
Score: 0.091
-
Primary oncocytic adenocarcinomas of the lung: a clinicopathologic, immunohistochemical, and molecular biologic analysis of 16 cases. Am J Clin Pathol. 2010 Jan; 133(1):133-40.
Score: 0.089
-
Agreement on Major Pathological Response in NSCLC Patients Receiving Neoadjuvant Chemotherapy. Clin Lung Cancer. 2020 07; 21(4):341-348.
Score: 0.045
-
Immune regulatory markers of lepidic-pattern adenocarcinomas presenting as ground glass opacities. J Thorac Dis. 2020 Mar; 12(3):329-337.
Score: 0.045
-
Micropapillary adenocarcinoma of lung: Morphological criteria and diagnostic reproducibility among pulmonary pathologists. Ann Diagn Pathol. 2019 Aug; 41:43-50.
Score: 0.043
-
Multiregion gene expression profiling reveals heterogeneity in molecular subtypes and immunotherapy response signatures in lung cancer. Mod Pathol. 2018 06; 31(6):947-955.
Score: 0.039
-
Primary Pulmonary Salivary Gland-type Tumors: A Review and Update. Adv Anat Pathol. 2016 Jan; 23(1):13-23.
Score: 0.034
-
Primary Pulmonary Lymphomas. Adv Anat Pathol. 2015 Nov; 22(6):355-75.
Score: 0.033
-
Intratumor heterogeneity in localized lung adenocarcinomas delineated by multiregion sequencing. Science. 2014 Oct 10; 346(6206):256-9.
Score: 0.031
-
Transcriptomic architecture of the adjacent airway field cancerization in non-small cell lung cancer. J Natl Cancer Inst. 2014 Mar; 106(3):dju004.
Score: 0.030
-
EZH2 protein expression associates with the early pathogenesis, tumor progression, and prognosis of non-small cell lung carcinoma. Clin Cancer Res. 2013 Dec 01; 19(23):6556-65.
Score: 0.029
-
Validation of a proliferation-based expression signature as prognostic marker in early stage lung adenocarcinoma. Clin Cancer Res. 2013 Nov 15; 19(22):6261-71.
Score: 0.029
-
G-protein coupled receptor family C, group 5, member A (GPRC5A) expression is decreased in the adjacent field and normal bronchial epithelia of patients with chronic obstructive pulmonary disease and non-small-cell lung cancer. J Thorac Oncol. 2012 Dec; 7(12):1747-1754.
Score: 0.027